Keyphrases
Gene Fusion
91%
Cervical Cancer
85%
Structural Variation
81%
Sequence Data
64%
Sequence Reads
60%
RNA Sequencing (RNA-seq)
57%
Tumor
44%
Split-read Mapping
39%
Low Coverage
38%
Prostate Cancer
31%
Genotype
29%
Small Interfering RNA (siRNA)
28%
RNA Expression
27%
Patient-derived Xenograft
27%
Breast Cancer
27%
Radiation Therapy
27%
Genomic Characterization
26%
Cervical Cancer Cells
26%
Chemoradiation
25%
SerpinB3
25%
Squamous Cell Carcinoma Antigen
25%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
25%
Estrogen Receptor 1 (ESR1)
25%
Mapping Method
24%
Transcriptome
24%
Overall Survival
23%
Rare Variants
23%
Transcriptomic Data
22%
Gene Expression
22%
Next-generation Sequencing Data
21%
Transcriptome Analysis
21%
Long Non-coding RNA (LncRNA)
20%
Cancer-related
20%
Standardized Uptake Value
19%
Chemoradiotherapy
18%
Radiotherapy
17%
Myeloid-derived Suppressor Cells
17%
Haplotype Inference
16%
Computational Approach
16%
Allele Frequency
16%
Neoantigen
16%
Acute Myeloid Leukemia
16%
HPV Genotyping
16%
Metastatic Tumor
16%
Statistical Test
16%
Therapeutic Strategies
16%
Radiosensitization
16%
Xenograft
16%
Whole Transcriptome
16%
Radiation Effects
16%
Biochemistry, Genetics and Molecular Biology
Genomics
100%
Gene Fusion
96%
RNA
79%
Indel
63%
Transcriptome
53%
RNA Sequencing
50%
RNA Sequence
47%
Genotyping
44%
Cancer Cell
44%
Gene Expression Profiling
44%
Genetic Divergence
41%
Overall Survival
40%
Exome
38%
Myeloid
31%
Next Generation Sequencing
30%
Estrogen Receptor
26%
Genetics
24%
Genetic Variation
22%
YAP1
22%
Gene Expression
20%
T Cell
19%
Gene Frequency
19%
Non-Coding RNA
19%
Metabolic Pathway
16%
P53
15%
Drive
15%
Tumor Progression
15%
Endogenous Retrovirus
12%
Radiosensitivity
12%
Glutaminase
12%
Clonal Evolution
12%
Mesenchymal-Epithelial Transition
12%
Cathepsin L
12%
Cell Death
12%
Isoform
12%
Bromodomain
12%
Chemokine
12%
Reprogramming
12%
Epigenetics
12%
Human Papillomavirus Type 16
12%
Ligand Binding Domain
12%
Drug Resistance
12%
Oxidative Stress
12%
Gene Amplification
12%
Radiosensitization
12%
Androgen Receptor
12%
Glutamine
12%
Genetic Drift
12%
Hormone Release
12%
Disease Burden
12%
Medicine and Dentistry
Cervical Cancer
93%
Neoplasm
74%
Radiation Therapy
45%
Gene Fusion
35%
Metastatic Carcinoma
35%
Chemoradiotherapy
35%
Cancer Cell
33%
Prostate Cancer
29%
RNA Sequencing
28%
Squamous Cell Carcinoma Antigen
25%
Overall Survival
25%
Biological Marker
21%
Transcriptome
20%
Malignant Neoplasm
17%
Disease
17%
Fluorodeoxyglucose F 18
16%
Standardized Uptake Value
16%
Uterine Cervix Carcinoma
15%
Macrophage
15%
CDK4/6 Inhibitor
14%
Breast Cancer
14%
Endogenous Retrovirus
12%
Fatty Acid
12%
Wart Virus
12%
Chemokine
12%
Tumor Resistance
12%
Lymph Duct
12%
Medulloblastoma
12%
Ovarian Cancer
12%
Minimal Residual Disease
12%
Prognostication
12%
Metastatic Breast Cancer
12%
Neutrophil
12%
Immunotherapy
12%
T-Cell Response
12%
RNA Sequence
12%
Estrogen Receptor Positive Breast Cancer
12%
Hormone Therapy
12%
Cathepsin L
12%
Prognosis
12%
Fibrolamellar Hepatocellular Carcinoma
12%
Immunity
12%
Oropharynx Carcinoma
12%
Primary Tumor
10%
Gene Expression
10%
Recurrent Disease
10%
The Cancer Genome Atlas
10%
Head and Neck Cancer
10%
Next Generation Sequencing
9%
Progression Free Survival
9%
